Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 07, 2026 01:05 ET | Source: Pharming Group N.V.

Pharming Group announces presentations at CIS 2026 Annual Meeting, including leniolisib pediatric data in APDS and clinical experience in CVID and related disorders

Pharming today announced presentations at the 2026 Annual Meeting of the Clinical Immunology Society (CIS) in New Orleans, LA.
February 03, 2026 01:00 ET | Source: Pharming Group N.V.

Pharming Group announces 2026 financial guidance and highlights rare disease pipeline at Investor Day

Pharming Group announces 2026 financial guidance and highlights rare disease pipeline (PIDs and PMD) at Investor Day today Feb. 3 at 10:00am EST.
October 01, 2025 01:00 ET | Source: Pharming Group N.V.

Pharming Group announces U.S. FDA acceptance and Priority Review of supplemental New Drug Application for leniolisib in children with APDS aged 4 to 11 years

Pharming sNDA for leniolisib in children aged 4-11 years with APDS accepted and granted Priority Review by FDA.